Overview
Today’s scan produced 12 continuation breakout signals, with the top 10 candidates spanning Medical/Biotech, Metals, Finance, Internet, Retail, Transportation and Software. Average RVOL across the group sits below 1.0 (roughly 0.83), meaning most breakouts are advancing without heavy volume confirmation — a hallmark of a Cautious regime where price often leads volume. Standouts like RDDT (+9.3%) and STLD (+5.8%) show real conviction, while several biotech names (RGNX, EBS, FDMT, NUVB) confirm that Health Care — one of today’s top-ATR% sectors — is contributing genuine leadership.
Sector concentration is moderate rather than a single theme trade: four Medical/Biotech names cluster together, but the remaining six candidates are spread across unrelated industries, suggesting broad (if uneven) market participation rather than a narrow rotation.
Quality Score: 3/5. The Cautious regime demands selectivity, and while institutional backing is strong in several names (RDDT, CVNA, SPOT, STLD all carry INST-flagged bucket status with 1,600+ funds), the below-average RVOL readings across the board keep this from being a top-tier breakout day. We are being selective with our Top 5.
Top 5 Picks
RDDT ($158.10) — Internet / Internet-Content
RDDT posted a powerful 9.3% move directly into a weekly demand zone (140.67–157, just 0.7% below price), with institutional backing from 1,669 funds in the INST bucket. The tight 1h supply zone (161.09–164.43) sits just above, giving a clean near-term reference for continuation. ATR%-M of -1.2 shows the stock is still range-compressed relative to its move, leaving room to expand toward supply.
| Level | Price |
|---|---|
| Entry | $158.00 |
| Stop | $148.50 |
| Target | $164.40 |
Institutional Backing: 1,669 funds, INST bucket (B1, B2).
CVNA ($74.16) — Retail / Retail-Automobile
CVNA is sitting right at a razor-tight 4h demand zone (73.31–73.95, just 0.28% away), backed by 2,001 funds and a positive ATR%-M of 1.7 signaling expanding volatility in its favor. This is a classic tight-risk continuation entry off strong institutional support.
| Level | Price |
|---|---|
| Entry | $74.00 |
| Stop | $72.50 |
| Target | $79.00 |
Institutional Backing: 2,001 funds, INST bucket (B1, B2).
SPOT ($559.36) — Software / Computer Sftwr-Edu/Media
SPOT holds the largest institutional footprint in today’s list at 3,138 funds, sitting at a monthly demand zone (443.21–548.55) with a weekly supply zone (575–586.53) just 2.8% overhead. ATR%-M of 3.3 confirms strong directional expansion, supporting a continuation push into that supply band.
| Level | Price |
|---|---|
| Entry | $559.00 |
| Stop | $545.00 |
| Target | $580.00 |
Institutional Backing: 3,138 funds, INST bucket.
STLD ($247.64) — Metals / Steel-Producers
STLD surged 5.8% with RVOL at 1.0, pressing right into daily supply (249.81–257.22, 0.88% away) with the deepest institutional bench of the day — 2,332 funds. A clean push through supply would confirm continuation; demand support below sits at 229.04–234.09.
| Level | Price |
|---|---|
| Entry | $248.00 |
| Stop | $234.00 |
| Target | $258.00 |
Institutional Backing: 2,332 funds, INST bucket (B2).
TNK ($90.75) — Transportation / Transportation-Ship
TNK carries the best RVOL of the group at 1.1 alongside the highest ATR%-M reading (4.4), indicating strong volatility expansion. Price is testing a 4h supply zone (92.39–94.30, 1.81% away) with a 30m demand base near 83.04–83.52 well below as structural support.
| Level | Price |
|---|---|
| Entry | $90.75 |
| Stop | $86.00 |
| Target | $94.30 |
Institutional Backing: 337 funds (B1, B2).
Honorable Mentions
FDMT ($14.94) — Health Care leader with ATR%-M of 3.0 and a tight demand zone, but lighter institutional base caps conviction.
NUVB ($6.93) — Solid biotech momentum with a 7.6-strength weekly demand zone, though positioned between zones rather than at one.
EZPW ($32.59) — At-demand setup with favorable supply/demand strength ratio, but RVOL of 0.5 limits urgency.
RGNX ($9.60) — Small biotech bounce, but negative ATR%-M and low RVOL keep this a watch-only name.
EBS ($6.46) — Decent institutional count (257 funds) but weak volume and negative ATR%-M reduce continuation odds.
Strategy Summary
Today’s continuation setups skew toward quality over quantity. While 12 signals fired, only a handful — RDDT, CVNA, SPOT, STLD, and TNK — combine strong institutional sponsorship, favorable zone positioning, and positive volatility expansion needed for high-conviction entries in a Cautious regime. Health Care/Biotech names dominate by count but lack the volume and institutional depth of the mega-cap Top 5. Risk/reward is best on CVNA and RDDT, where tight demand zones allow controlled stops; STLD and TNK require confirmation through nearby supply before full commitment. Overall, this is a selective day — trade the leaders, watch the rest.